Connected Facts

Crude stroke mortality rates among older US adults (aged ≥65 years), 2005 to 2015

Source: Centers for Disease Control and Prevention

Prevalence & Incidence, Age - A Major Risk Factor, Human Burden, Future Human Burden

Female Stroke Inpatients Outnumber Males in 85+ population

In 2014, females ≥85 years constituted 66.0% of all inpatient hospital stays for stroke patients.

Human Burden, Economic Burden

Stroke

Average Length of Hospital Stay for Stroke Patients

The average length of stay for hospitalized stroke patients was 4.7 days in 2014.

Human Burden, Economic Burden

Stroke

2015 Female Stroke Deaths

In 2015, females accounted for 58% of stroke-related deaths in the US.

Prevalence & Incidence, Human Burden

Stroke

Highest and Lowest Stroke Prevalence by State in U.S. Adults

2.7% of U.S. adults suffer from stroke, with the highest prevalence in Alabama (4.3%) and the lowest prevalence in Minnesota (1.9%).

Prevalence & Incidence, Human Burden

Stroke

African Americans in Southeastern U.S. and Stroke Burden

African Americans and those living in the southeastern United States experience the greatest
disease burden of stroke.

 

Prevalence & Incidence, Age - A Major Risk Factor, Human Burden, Future Demographics

Related Facts

• Use of ACE inhibitor drugs for people with congestive heart failure helped avoid $9,000 per person in hospital costs over a 3-year period and reduced deaths by 16%.  [ Get More Details ]
• Increased use of a blood-thinning drug saves $600 million annually, because of the strokes it prevents.  [ Get More Details ]

• Cost-effectiveness of SAVR

  The cost-effectiveness ratio for surgical aortic valve replacement (SAVR), compared to no surgery, was estimated at $13,528 per quality-adjusted life year (QALY) (~$17,225 in 2017 dollars).  [ Get More Details ]
• Every additional dollar spent on the routine use of beta-blockers (versus under-use) in acute heart attack patients has produced health gains valued as high as $38.44.  [ Get More Details ]
• Use of antihypertensive therapies avoided an estimated $10.7 billion in 2002 direct medical costs as a result of fewer strokes. They also avoided an estimated $5.8 billion in 2002…  [ Get More Details ]